China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
China SXT Pharmaceuticals Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
China SXT Pharmaceuticals Inc 的收入按细分市场或地理位置如何划分?
China SXT Pharmaceuticals Inc 最大收入来源是 Advanced Traditional Chinese Medicine Pieces,在最近的收益报告中收入为 946,015。就地区而言, China 是 China SXT Pharmaceuticals Inc 的主要市场,收入为 1,928,497。